Skip to content

Psilocybin: all studies

Page 275 of 441: studies 2,741 to 2,750 of 4,401, newest first. Back to the psilocybin overview

Research

Hallucinogen Persistent Perception Disorder Induced by New Psychoactive Substituted Phenethylamines; A Review with Illustrative Case

Current Psychiatry Reviews August 10, 2016 Cornel N. Stanciu, Thomas M. Penders 3 citations

Hallucinogen Persistent Perception Disorder (HPPD) is considered an “uncommon” disorder described in association with use of hallucinogens such as LSD, mescaline and psilocybin. Despite multiple mentions of persistence of visual disturbances reported by users on online forums, clinicians may not be aware of this complication. There have been few descriptions of HPPD in association with use of...

Hallucinogens and dissociative drugs

Oxford University Press eBooks August 1, 2016 15 citations

Abstract Chapter 15 of Addiction Medicine covers hallucinogens and dissociative drugs. Hallucinogens are a large and diverse group of substances, some of which occur in fungi and plants and some which are chemically synthesized. Psychostimulants described in this chapter include psilocybin, mescaline, ayahuasca, lysergic acid diethylamide (LSD), and NBOMes and tryptamines. Dissociative drugs...

Hallucinogen Use Disorders.

Child and Adolescent Psychiatric Clinics of North America July 2016 Rashad Hardaway, Jason Schweitzer, Joji Suzuki

Use of hallucinogenic substances as a public health concern has increased over the past decade. Among adolescents, there are increasing emergency department presentations for intoxication with these drugs, contrary to decreasing reported use of classical hallucinogens such as LSD. Academic and governmental groups have monitored use of hallucinogens, highlighting a notable change in perceptions...

Entwicklung des Missbrauchs psychotroper Pflanzen und Pilze in Deutschland – Interpretation der Zahlen aus 3 Giftinformationszentren für die Jahre 2007–2013

Das Gesundheitswesen June 14, 2016 Jörg Pietsch, K. Scheffel, Daniela Acquarone et al. 2 citations

AIM OF THE STUDY: Based on an abundance of information on the internet, psychotropic plants and mushrooms are of increasing relevance as legal and cheap alternatives to other illicit drugs. Due to the lack of a German database, the abuse of selected biogenic drugs using reported exposures to 3 German Poison Information Centres (PICs) was examined. METHODS: Information on abuse of biogenic drugs...

DOI: 10.1055/s-0042-108644 (opens in new tab) Psilocybin Tropane Drugs of abuse Hallucinogen

Exploring Hallucinogen Pharmacology and Psychedelic Medicine with Zebrafish Models

Zebrafish March 22, 2016 Evan J. Kyzar, Allan V. Kalueff 29 citations

After decades of sociopolitical obstacles, the field of psychiatry is experiencing a revived interest in the use of hallucinogenic agents to treat brain disorders. Along with the use of ketamine for depression, recent pilot studies have highlighted the efficacy of classic serotonergic hallucinogens, such as lysergic acid diethylamide and psilocybin, in treating addiction, post-traumatic stress...

Ayahuasca: Pharmacology, neuroscience and therapeutic potential

Brain Research Bulletin March 11, 2016 Elisabet Domínguez‐clavé, Joaquim Soler, Matilde Elices et al. 220 citations

Ayahuasca is the Quechua name for a tea obtained from the vine Banisteriopsis caapi, and used for ritual purposes by the indigenous populations of the Amazon. The use of a variation of the tea that combines B. caapi with the leaves of the shrub Psychotria viridis has experienced unprecedented expansion worldwide for its psychotropic properties. This preparation contains the psychedelic 5-HT2A...

The “Endless Trip”: Psychopathology and psychopharmacology in the Hallucinogen Persisting Perception Disorder (HPPD)

European Psychiatry March 1, 2016 Laura Orsolini, Alessandro Valchera, Duccio Papanti et al. 3 citations

Introduction Hallucinogen Persisting Perception Disorder (HPPD) is a syndrome characterized by prolonged or reoccurring perceptual symptoms, reminiscent of acute hallucinogen effects. HPPD was associated with a broader range of LSD (lysergic acid diethylamide)-like substances, including cannabis, MDMA (methylenedioxymethamphetamine), psilocybin, mescaline and other psychostimulants....

The paradoxical psychological effects of lysergic acid diethylamide (LSD)

Psychological Medicine February 5, 2016 Robin Carhart-Harris, Mendel Kaelen, Mark Bolstridge et al. 301 citations

Background Lysergic acid diethylamide (LSD) is a potent serotonergic hallucinogen or psychedelic that modulates consciousness in a marked and novel way. This study sought to examine the acute and mid-term psychological effects of LSD in a controlled study. Method A total of 20 healthy volunteers participated in this within-subjects study. Participants received LSD (75 µ g, intravenously) on one...

Classic hallucinogens in the treatment of addictions.

Progress in Neuro-Psychopharmacology and Biological Psychiatry January 4, 2016 Michael P. Bogenschutz, Matthew W Johnson

Addictive disorders are very common and have devastating individual and social consequences. Currently available treatment is moderately effective at best. After many years of neglect, there is renewed interest in potential clinical uses for classic hallucinogens in the treatment of addictions and other behavioral health conditions. In this paper we provide a comprehensive review of both...

The epistemic innocence of psychedelic states.

Consciousness and Cognition 2016 Chris Letheby 68 citations

One recent development in epistemology, the philosophical study of knowledge, is the notion of 'epistemic innocence' introduced by Bortolotti and colleagues. This concept expresses the idea that certain suboptimal cognitive processes may nonetheless have epistemic (knowledge-related) benefits. The idea that delusion or confabulation may have psychological benefits is familiar enough. What is...